Karron RA and Collins PL. “Parainfluenza Viruses.” In: Fields Virology, DM Knipe and PM Howley (eds.), 5th edition, WB Saunders & Co., Philadelphia, PA, 2007.
Greenberg DP, Walker RE, Lee M-S, Reisinger KS, Ward JI, Yogev R, Blatter MM, Yeh SH, Karron RA, Sangli C, Coelingh KL, Cordova JM, August MJ, Mehta HB, Chen W, Mendelman PM. A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy. J Infect Dis. 2005;191(7):1116-1122. Karron RA, Belshe RB, Wright PF, Thumar B, Burns B, Newman F, Thompson J, Murphy BR. A live human parainfluenza type 3 vaccine is attenuated and immunogenic in young infants. Ped Infect Dis J. 2003;22:394-405. Karron RA, Makhene M, Gay K, Wilson MH, Clements ML, Murphy BR. Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in 2-to-6-month-old infants. Ped Infect Dis J. 1996; 15:650-4. Karron RA, Wright PF, Hall SL, Makhene M, Thompson J, Burns BA, Tollefson S, Steinhoff MC, Wilson MH, Harris DO, Clements ML, Murphy BR. A live attenuated bovine parainfluenza type 3 virus vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. J Infect Dis. 1995; 171:1107-14. Karron RA, Wright PF, Newman FK, Makhene M, Thompson J, Samorodin R, Wilson MH, Anderson EA, Clements ML, Murphy BR, Belshe RB. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children. J Infect Dis. 1995; 172: 1445-50.
|
